Robitussin Cough Syrup Recalled Due to Microbe Contamination

The cold and flu remedies are contaminated with microbes that could cause fungal infections.

On January 24, Haleon, the maker of Robitussin and other over-the-counter cold and flu medications, recalled eight lots of Adult Robitussin Honey cough syrups because of microbial contamination. The medications are cough suppressant formulas that also reduce fever and body aches.

Although the recall alert does not specify what type of microbe has contaminated the products, the company says people with compromised immune systems who use the affected syrups could experience disseminated fungal infection or fungemia — a bloodstream infection caused by fungi or yeasts.

However, Haleon notes that illnesses requiring medical treatment occurring in non-immunocompromised individuals cannot be ruled out.

To date, the company has not received reports of infection or other adverse events related to the recalled products.

Cough medicines included in the recall are:

  • Robitussin Honey CF Max Day Adult 4-ounce — lot number T10810 (expiration date October 31, 2025).
  • Robitussin Honey CF Max Day Adult 8-ounce — lot numbers T08730, T08731, T08732, T08733 (Expires May 31, 2025) and T10808 (expires September 30, 2025).
  • Robitussin Honey CF Max Nighttime Adult 8-ounce — lot numbers T08740 and T08742 (expires June 30, 2026).

Consumers can find lot numbers and expiration dates on the bottom right portion of the dosing instruction label.

Robitussin Recalled Product Image
Robitussin Honey CF Max Day Adult 8-ounce pictured in center (image by melissamn via Shutterstock)

Haleon says that people who have purchased the recalled cough syrups should stop using them immediately.

In addition, the company urges consumers to contact their healthcare provider if they have experienced any issues that could be related to the recalled cough syrups.

Note:
Consumers who have used Robitussin Honey CF Max for Adults can call Haleon's consumer relations team at 1-800-245-1040 (Monday through Friday, 8 AM to 6 PM Eastern Time) or reach out via email to [email protected] if they have questions or concerns. They can also report adverse events to the FDA's MedWatch Adverse Event Reporting program.


Leave a reply

Your email will not be published. All fields are required.